Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Inventory (2017 - 2022)

Acro Biomedical has reported Inventory over the past 6 years, most recently at $296000.0 for Q3 2022.

  • Quarterly results put Inventory at $296000.0 for Q3 2022, down 33.93% from a year ago — trailing twelve months through Sep 2022 was $296000.0 (down 33.93% YoY), and the annual figure for FY2020 was $938000.0, up 6.77%.
  • Inventory for Q3 2022 was $296000.0 at Acro Biomedical, roughly flat from $296000.0 in the prior quarter.
  • Over the last five years, Inventory for ACBM hit a ceiling of $1.1 million in Q3 2018 and a floor of $296000.0 in Q2 2022.
  • Median Inventory over the past 5 years was $878560.0 (2019), compared with a mean of $722691.8.
  • Biggest five-year swings in Inventory: skyrocketed 252.63% in 2019 and later crashed 66.98% in 2020.
  • Acro Biomedical's Inventory stood at $360000.0 in 2018, then skyrocketed by 144.04% to $878560.0 in 2019, then grew by 6.77% to $938000.0 in 2020, then crashed by 52.24% to $448000.0 in 2021, then plummeted by 33.93% to $296000.0 in 2022.
  • The last three reported values for Inventory were $296000.0 (Q3 2022), $296000.0 (Q2 2022), and $448000.0 (Q3 2021) per Business Quant data.